Foundayo: The new weight loss pill approved for the UK Foundayo has been approved for treating weight loss as well as type 2 diabetes The Independent UK · Aug 11
Semaglutide Was Linked to Fewer Fractures in People with Type 2 Diabetes Despite Greater Weight Loss A study of nearly 60,000 adults with type 2 diabetes found semaglutide was associated with 15% fewer fractures than other weight-loss medications. Medical Daily · Aug 10
As Southwest flight landed, Chicago girl with Type-1 diabetes had a terrifying drop in blood sugar, but crew allegedly only told them to ‘sit down’ “It is life and death and the way this family was treated is abhorrent!” We Got This Covered · Aug 10
Zambia’s national health insurance cuts costs for older people, but funding gaps limit its potential – study As people age, they are more likely to experience chronic illnesses such as hypertension (high blood pressure), diabetes and heart disease that require regular medical attention. Yet many older adults can’t afford healthcare. The Conversation · Aug 10
Nearly a Third of Women Under 45 Are Projected to Have Cardiovascular Disease Within 25 Years An American Heart Association statement projects nearly a third of women aged 20 to 44 will have cardiovascular disease by 2050, up from under a quarter. Medical Daily · Aug 10
When Parents Should Put a School-Lunch Accommodation Request in Writing For many families, school lunch is more than a daily meal—it can directly affect a child’s health, safety, and ability to learn. Whether a student has a life-threatening food allergy, diabetes, celiac disease, or another medical condition, clear written accommodations can help prevent confusion and reduce unnecessary risks. While schools… Kids Ain't Cheap · Aug 9
Psoriasis and Heart Disease Risk: What the Inflammation Link Means for Your Cardiovascular Health The inflammation that shows on your skin is also inside your arteriesPsoriasis is classified as a systemic autoimmune disease, which means the immune malfunction behind your skin plaques is not confined to the surface. The same cytokines, particularly TNF-alpha, IL-17, and IL-23, that drive skin inflammation also accelerate atherosclerosis, the… Times Life · Aug 9
Bank of America is splashing out $250 million a year on weight loss drugs for its staff: ‘We see a great impact on employees,’ CEO says Weight-loss drugs are becoming a popular perk, with almost a third of workers saying they’d even switch jobs for it. Bank of America has them covered. Fortune · Aug 7
Diabetes Education Programs Are Adding Medication Instruction as Regimens Get Harder to Manage A medication education program will reach ADA-recognized diabetes education sites in October. Why modern diabetes regimens are harder to teach and manage. Medical Daily · Aug 7
Researchers found how smoking, diabetes and high blood pressure may affect Alzheimer's and vascular dementia differently New research indicates dementia risk factors impact the brain uniquely. Common vascular risks damage brain blood vessels and white matter. Diabetes and lower BMI showed links to Alzheimer's proteins. This study highlights dementia's varied causes and mechanisms. Healthy habits may protect the brain through multiple pathways. The Economic Times · Aug 7
Three Midlife Health Habits Could Delay Dementia by More Than a Decade, Study Finds A new study links avoiding smoking, managing blood pressure, and controlling diabetes in midlife to nearly 13 more years of dementia-free living. Medical Daily · Aug 6
Three Midlife Health Factors Are Linked to Nearly Thirteen More Dementia Free Years, a Long Term Study Finds A 12,409-person study links normal blood pressure, no diabetes, and not smoking in midlife to nearly 13 more dementia-free years. What it shows. Medical Daily · Aug 6
The Nearest Indian Health Service Facility Is More Than a Two Hour Drive Out of State for Most Lumbee Citizens Federal recognition made Lumbee citizens eligible for IHS, but the nearest facility is out of state. What eligibility does and does not provide. Medical Daily · Aug 6
Lilly Files Its GLP-1 Pill for Diabetes, and the Manufacturing Case Is Stronger Than the Access Case Lilly submitted its oral GLP-1 for type 2 diabetes. Why pills are easier to manufacture than injectables, and why coverage still decides access. Medical Daily · Aug 6
Barchart · Aug 6 Eli Lilly Stock: Analyst Estimates & Ratings Eli Lilly's market-beating performance has done little to temper Wall Street's optimism, with analysts continuing to see meaningful upside in the stock.
Euronews · Aug 6 Weight-loss drugs tied to lower fracture risk in diabetes patients, study finds Weight-loss medicines linked to 21% lower fracture risk in type 2 diabetes patients, a new study found, challenging assumptions that rapid weight loss inevitably raises fracture risk.
The Independent UK · Aug 6 Weight loss drug linked to lower heart attack risk in diabetes patients, study finds IN FULL
The Independent UK · Aug 5 Diabetes drug Mounjaro found to cut heart attack risk by a third for first time Those receiving the drug were found to be 33 per cent less likely to suffer a heart attack when compared to patients on another type 2 diabetes medication
The Independent UK · Aug 5 Three middle-age health habits that could delay dementia for 13 years A new study recommends people actively avert certain factors in midlife ‘as a strategy for preserving brain health’
Evening Standard · Aug 5 Avoiding three things in middle age ‘linked to 13 extra years without dementia’ Researchers found having normal blood pressure, no diabetes and not smoking all had a positive effect on dementia risk.
Benzinga · Aug 5 Eli Lilly's Weight-Loss Empire Keeps Expanding As Mounjaro, Zepbound Generate Nearly $15 Billion Eli Lilly and Co. (NYSE:LLY) stock traded higher Wednesday after the drugmaker reported second-quarter results that topped Wall Street expectations and raised its full-year revenue outlook, driven by continued demand for its diabetes and obesity treatments.
Medical Daily · Aug 4 VA Launches a Randomized Trial Testing Whether Semaglutide Can Reduce Drinking in Veterans The VA opened enrollment in CRAVE, a placebo-controlled trial of semaglutide for alcohol use disorder in more than 600 veterans at 18 medical centers.
Medical Daily · Aug 4 VA Begins Enrolling 600 Veterans in Trial Testing Whether Semaglutide Reduces Alcohol Use The VA launched a placebo-controlled trial of semaglutide for alcohol use disorder in 600 veterans. No results exist yet. Here is what it tests.
The Times of India · Aug 4 How people in Chile's Atacama Desert evolved to survive drinking arsenic-poisoned water For most of human history, a water source containing high concentrations of arsenic would have been considered deadly. Long-term exposure to the toxic metal is linked to cancers, cardiovascular disease, diabetes and neurological disorders. Yet for thousands of years, people living in Chile's Atacama Desert have relied on groundwater containing…
The Economic Times · Aug 4 Government tightens surveillance on GLP-1 weight-loss drug promotion amidst surrogate advertising concerns Central government directs state regulators to enhance surveillance over GLP-1 drug promotion. Approved GLP-1 drugs are only for Type 2 diabetes and specific weight management. Advisories were issued to manufacturers and drug controllers regarding product information. Regulators must monitor supply chains and take action against diversion. Advertising platforms will be…